Table 3.
Presence and ORs of high risks of CHD and stroke according to CKD groups
Stages | High CHD risk | High stroke risk | ||
---|---|---|---|---|
n (%) | OR (95% CI) | n (%) | OR (95% CI) | |
No CKD (n = 853) | 317 (37.2) | – | 90 (10.6) | – |
CKD Stages 1–2 (n = 428) | 216 (50.5) | 1.7 (1.4–2.2)* | 79 (18.5) | 1.9 (1.4–2.7)* |
CKD Stages 3–5 (n = 120) | 81 (67.5) | 3.5 (2.3–5.3)* | 59 (49.2) | 8.2 (5.4–12.5)* |
*P<0.001 compared to cases no CKD. The 10-year CHD and stroke risks were estimated using the UK prospective diabetes study risk engine, and individuals were categorized as having low (<10%), intermediate (10–20%) or high (>20%) 10-year risk. ORs were calculated with binary logistic regression analysis. CHD: Coronary heart disease; CKD: Chronic kidney disease; OR: Odds ratio; CI: Confidence interval; UACR: Urine albumin–to–creatinine ratio; –: Not applicable.